Louis Bock Insider Profile
4 Followers
Louis Bock, Director at Scorpius Holdings, holds 0.00 shares in Scorpius Holdings (Ticker: SCPX), holds 28.38K shares in Orexigen (Ticker: OREXQ), holds 436.00 shares in Zogenix (Ticker: ZGNX).
Louis Bock's Trading History
| OREXQOrexigen | Nov 19, 2014 | ― | Informative Buy | 7.38K | $141.88 | |
| ZGNXZogenix | Sep 21, 2011 | ― | Informative Buy | 2.50M | $11.63K | |
| HZNPHorizon Therapeutics | Aug 04, 2011 | ― | Informative Buy | 4.66M | $256.38M | |
| SOMXSomaxon Pharmaceuticals | ― | ― | ― | ― | ||
| DVAXDynavax | ― | ― | ― | $3.32M | ||
| SCPXScorpius Holdings | ― | Director | ― | $0.00 |
You May Also Like
Louis Bock insider profile FAQ
What is the percentage of profitable transactions made by Louis Bock?
The percentage of profitable transactions made by Louis Bock is 0%.
What is the average return per transaction made by Louis Bock?
The average return per transaction made by Louis Bock is -57.30%.
What stocks does Louis Bock hold?
Louis Bock holds: SCPX, ZGNX, OREXQ, HZNP, DVAX, SOMX stocks.
What was Louis Bock's most profitable transaction?
Louis Bock’s most profitable transaction was an Informative Buy of OREXQ stock on November 12, 2014. The return on the trade was -56.60%.
What is Louis Bock's role in Scorpius Holdings?
Louis Bock's role in Scorpius Holdings is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
